Company Filing History:
1 out of 85 
1 out of 6 Years Active: 2021
Title: Michel Malaise: Innovator in Early Diagnosis of Immune-Mediated Inflammatory Diseases
Introduction
Michel Malaise is a notable inventor based in Liege, Belgium. He has made significant contributions to the field of medical diagnostics, particularly in the early detection of immune-mediated inflammatory diseases. His innovative approach has the potential to improve patient outcomes through timely diagnosis.
Latest Patents
Michel Malaise holds a patent for a method of early diagnosis of immune-mediated inflammatory disease. This in-vitro method involves obtaining a sample from a subject and quantifying the presence of specific biomarkers. The method utilizes a single LC/MS-MS analysis to detect the presence of the V65 vitronectin fragment and complement C3f, along with their variants or degradation products. This innovative technique represents a significant advancement in the field of medical diagnostics.
Career Highlights
Throughout his career, Michel Malaise has worked with esteemed institutions such as Université de Liège and Centre Hospitalier Universitaire de Liège. His work in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
One of his notable collaborators is Dominique De Seny, with whom he has worked on various projects related to immune-mediated diseases. Their partnership has fostered advancements in understanding and diagnosing these complex conditions.
Conclusion
Michel Malaise's contributions to the field of medical diagnostics, particularly through his patented method for early diagnosis of immune-mediated inflammatory diseases, highlight his role as an innovator. His work continues to pave the way for advancements in patient care and medical research.